Kumquat Biosciences

Kumquat Biosciences is a biotechnology company focused on developing innovative treatments for cancer, particularly targeting KRAS mutations that occur in various cancers such as pancreatic, colorectal, and lung cancers. The company recently gained attention for its partnership with Bayer, which is valued at up to $1.3 billion, aimed at advancing the development of a promising new cancer drug.